Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer

BACKGROUND: A number of clinico-pathological criteria and molecular profiles have been used to stratify patients into high- and low-risk groups. Currently, there are still no effective methods to determine which patients harbor micrometastatic disease after standard breast cancer therapy and who wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Legendre, Christophe, Gooden, Gerald C., Johnson, Kyle, Martinez, Rae Anne, Liang, Winnie S., Salhia, Bodour
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573288/
https://www.ncbi.nlm.nih.gov/pubmed/26380585
http://dx.doi.org/10.1186/s13148-015-0135-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573288/
https://www.ncbi.nlm.nih.gov/pubmed/26380585
http://dx.doi.org/10.1186/s13148-015-0135-8

Ejemplares similares